NO932097D0 - Myke farmasoeytiske kapsler som inneholder lysinclonixinatog fremgangsmaate for deres fremstilling - Google Patents

Myke farmasoeytiske kapsler som inneholder lysinclonixinatog fremgangsmaate for deres fremstilling

Info

Publication number
NO932097D0
NO932097D0 NO932097A NO932097A NO932097D0 NO 932097 D0 NO932097 D0 NO 932097D0 NO 932097 A NO932097 A NO 932097A NO 932097 A NO932097 A NO 932097A NO 932097 D0 NO932097 D0 NO 932097D0
Authority
NO
Norway
Prior art keywords
lysinclonixinatog
procedure
preparation
caps containing
soft pharmaceutical
Prior art date
Application number
NO932097A
Other languages
English (en)
Other versions
NO932097L (no
Inventor
Carlos A Vasqez
Original Assignee
Roemmers Saicf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roemmers Saicf filed Critical Roemmers Saicf
Publication of NO932097D0 publication Critical patent/NO932097D0/no
Publication of NO932097L publication Critical patent/NO932097L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO932097A 1992-06-16 1993-06-09 Myke farmasoeytiske kapsler som inneholder lysinclonixinat og fremgangsmaate for deres fremstilling NO932097L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4219702A DE4219702A1 (de) 1992-06-16 1992-06-16 Pharmazeutische Weichkapseln enthaltend Lysinclonixinat und ein Verfahren zu dessen Herstellung

Publications (2)

Publication Number Publication Date
NO932097D0 true NO932097D0 (no) 1993-06-09
NO932097L NO932097L (no) 1993-12-17

Family

ID=6461132

Family Applications (1)

Application Number Title Priority Date Filing Date
NO932097A NO932097L (no) 1992-06-16 1993-06-09 Myke farmasoeytiske kapsler som inneholder lysinclonixinat og fremgangsmaate for deres fremstilling

Country Status (13)

Country Link
EP (1) EP0574822A1 (no)
JP (1) JPH0665078A (no)
KR (1) KR940000108A (no)
CN (1) CN1037934C (no)
AU (1) AU656078B2 (no)
CA (1) CA2098410A1 (no)
DE (1) DE4219702A1 (no)
FI (1) FI932768A (no)
IE (1) IE930446A1 (no)
IL (1) IL105870A (no)
MX (1) MX9303582A (no)
NO (1) NO932097L (no)
ZA (1) ZA934222B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19849848A1 (de) * 1998-10-29 2000-05-04 Lohmann Therapie Syst Lts Oral applizierbare, mit Flüssigkeit spontan zerfallende therapeutische Darreichungsform und Verfahren zu ihrer Herstellung
KR20030042935A (ko) * 2001-11-26 2003-06-02 알앤피코리아 주식회사 클로닉신리신 제제

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3337570A (en) * 1965-10-23 1967-08-22 Schering Corp Substituted nicotinic acids and method for the manufacture thereof
US4141976A (en) * 1976-01-05 1979-02-27 The Regents Of The University Of Michigan Process for alleviating proliferative skin diseases
DE4037554A1 (de) * 1990-11-26 1992-05-27 Roemmers Sa Arzneimittel zur topischen anwendung

Also Published As

Publication number Publication date
EP0574822A1 (de) 1993-12-22
MX9303582A (es) 1994-04-29
CA2098410A1 (en) 1993-12-17
AU656078B2 (en) 1995-01-19
IE930446A1 (en) 1993-12-29
FI932768A (fi) 1993-12-17
ZA934222B (en) 1994-01-17
JPH0665078A (ja) 1994-03-08
FI932768A0 (fi) 1993-06-16
DE4219702A1 (de) 1993-12-23
AU4000993A (en) 1993-12-23
KR940000108A (ko) 1994-01-03
CN1083702A (zh) 1994-03-16
NO932097L (no) 1993-12-17
IL105870A (en) 1996-12-05
CN1037934C (zh) 1998-04-08
IL105870A0 (en) 1993-10-20

Similar Documents

Publication Publication Date Title
FI946064A (fi) Apuaineita sisältävä rokotekoostumus
DK647087D0 (da) Substituerede basiske tetraliner, fremgangsmaade til deres fremstilling samt deres anvendelse som laegemidler
FI925615A0 (fi) Stabiliserade farmaceutiska kompositioner, som innehaoller en hmg-coa-reduktas-inhibitorfoerening
FI954767A (fi) Lipofiilisiä lääkeaineita sisältävä farmaseuttinen koostumus
NO943044L (no) Formuleringer som inneholder hyaluronsyre
PT589843E (pt) Composicoes farmaceuticas contendo ciclosporinas
BR9408457A (pt) Preparação farmacêutica percutânia
DE10199046I2 (de) Rapamycin-Zubereitungen zur oralen Verabreichung
DK488885D0 (da) 9-amino-1,2,3,4-tetrahydroacridin-1-ol og beslaegtede forbindelser, enfremgangsmaade til deres fremstilling og deres anvendelse som laegemidler
NO922940D0 (no) Fem-leddete heterocykliske forbindelser, fremgangsmaate for deres fremstilling og legemidler inneholdende dem
NO881164L (no) Substituerte 9-amino-tetrahydroakridiner og relaterte forbindelser, en fremgangsmaate for deres fremstilling og deres bruk som medikamenter.
FI925633A0 (fi) Foerfarande foer framstaellning av en farmaceutisk sammansaettning som selektivt saenker lipidnivaon i blodet
DK593883A (da) Substituerede phenylsulfonyloxybenzimidazolcarbaminater, fremgangsmaade til deres fremstilling og deres anvendelse som laegemiddel
DK539087A (da) 4,5-dihydro- og 4,5,6,7-tetrahydro-pyrazolooe1,5-aaapyrimidiner, fremgangsmaader til deres fremstilling samt deres anvendelse som laegemidler
NO960272D0 (no) Oksatiolaner, fremgangsmåte for deres fremstilling og farmasöytiske preparater som inneholder de samme
DK303688D0 (da) Polyoxygenerede labdanderivater, fremgangsmaade til deres fremstilling samt deres anvendelse som laegemidler
NO930796D0 (no) Glykopeptidderivater, fremgangsmaate for deres fremstilling og farmasoeytiske midler inneholdende disse
DK393788A (da) Substituerede thienoimidazolderivater, fremgangsmaader til deres fremstilling samt deres anvendelse som laegemidler
DK401988D0 (da) 11-substituerede 5-aryl-5h,11h-pyrrolo(2,1-c)-(1,4)benzoxazepiner, fremgangsmaade til deres fremstilling samt deres anvendelse som laegemidler
NO932097D0 (no) Myke farmasoeytiske kapsler som inneholder lysinclonixinatog fremgangsmaate for deres fremstilling
DK259088A (da) Diarylalkyl-substituerede alkylaminer, fremgangsmaader til deres fremstilling samt deres anvendelse som laegemidler
DK225189D0 (da) Hydrazinocarbonyloxylabdaner, fremgangsmaade til deres fremstilling samt deres anvendelse som laegemidler
NO940533D0 (no) Rensede streptograminer, deres fremstilling samt farmasöytiske preparater inneholdende forbindelsene
DK37589D0 (da) Farmaceutisk praeparat for 4-aroylimidazol-2-oner
FI954348A0 (fi) Säädetysti vapauttava alumiinia sisältävä farmaseuttinen valmiste